WY Lau

Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice.

R. Edwards, W. Lau, S. Ho, 2000, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

'Hepatoma-specific' alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease.

P. Johnson, S. Ho, S. Yu, 1997, British Journal of Cancer.

Isoelectric focusing of alphafetoprotein in patients with hepatocellular carcinoma--frequency of specific banding patterns at non-diagnostic serum levels.

A. Li, W. Yeo, A. Chan, 1996, British Journal of Cancer.